Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial.
Lung cancer (LC) screening with low-dose computed tomography (LDCT) reduces mortality through early-stage detection, yet evidence on long-term effectiveness and adherence remains limited. This study reports nearly 10-year outcomes from the prospective BioMILD trial, which enrolled 4,119 heavy smokers undergoing risk-ad...